Beckman Coulter and Premier Sign Agreements for Diagnostic Laboratory Systems and Supplies
Beckman Coulter, Inc. has signed several new three-year agreements with Premier, Inc., effective March 31, 2004. The new contracts — which include pricing agreements for Beckman Coulter’s chemistry, immunoassay, hematology and automation systems, services and supplies — are expected to generate approximately $130 million in revenue per year for Beckman Coulter.
“These agreements provide Premier members with access to an extensive menu of product offerings, from routine tests like complete blood counts to specialty tests for cancer, cardiovascular disease, diabetes and more,” said Robert Kleinert, vice president of the Americas for the clinical diagnostics division of Beckman Coulter. “In addition, the agreements now encompass our full range of automation equipment, including more than 30 systems and
modules. These systems and tests are uniquely suited to help improve lab processes to make hospitals and health networks more efficient and cost-effective.”
The agreements include Beckman Coulter’s new UniCel(R) DxI 800 Access(R) immunoassay system, which can perform up to 400 tests per hour — the highest throughput of any random-access immunoassay system on the market. The DxI 800 test menu features approximately 40 tests in the United States, including cardiac, cancer, anemia, infectious disease, reproductive and other endocrine tests.
Other new systems on contract include the LH 1500 series hematology automation system, which manages the entire hematology testing process, from pre-analytical sorting to post-analytical storage; the SYNCHRON LX(R)i 725 clinical system, which combines chemistry and immunoassay testing with data management and automated sample handling on a single platform; and the COULTER(R) LH 500 hematology analyzer for fast, accurate blood cell counts.
In addition, Premier members will continue to access contracts for hundreds of other Beckman Coulter tests and instruments, such as the Access(R) 2 immunoassay system, COULTER(R) LH 700 series hematology analyzers and the SYNCHRON LX20 PRO clinical system.
Premier, Inc., is a strategic alliance in U.S. healthcare, entirely owned by more than 200 of the nation’s leading hospital and healthcare systems. These systems operate or are affiliated with nearly 1,500 hospital facilities and hundreds of other healthcare sites. Premier provides an array of resources supporting health services delivery including group purchasing for more than
$17 billion annually in supplies and equipment. Other resources offered by Premier are supply chain and clinical performance improvement services and insurance programs. Headquartered in San Diego, Premier has other major facilities in Chicago, IL; Charlotte, NC; and Washington, DC. For more information, visit www.premierinc.com .
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum — from systems biology and clinical research to laboratory diagnostics and point-of-care testing — Beckman Coulter’s 200,000 installed systems provide essential biomedical
information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2003 annual sales of $2.2 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com .
